CVS Stock Rises Ahead Of Lost Tobacco Sales
STEVE INSKEEP, HOST:
Less than a week after CVS announced its decision to stop selling tobacco products, the company's stock is on the rise. Share prices were up 2.3 percent yesterday, after posting higher-than-expected quarterly profits.
RENEE MONTAGNE, HOST:
CVS reports it processed more prescriptions and benefited from the introduction of new generic drugs last quarter. Company executives say they hope these sales trends offset a predicted drop in revenue. The ubiquitous pharmacy chain projects it will lose $1.5 billion every year from not selling cigarettes.
NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.